Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | malate dehydrogenase, putative | 0.0146 | 1 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Plasmodium vivax | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE MALATE DEHYDROGENASE MDH | 0.0073 | 0 | 0.5 |
Plasmodium vivax | lactate dehydrogenase | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0073 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable malate dehydrogenase Mdh | 0.0073 | 0 | 0.5 |
Giardia lamblia | Malate dehydrogenase | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trypanosoma cruzi | glycosomal malate dehydrogenase, putative | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Echinococcus granulosus | malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Entamoeba histolytica | malate dehydrogenase,cytoplasmic, putative | 0.0073 | 0 | 0.5 |
Echinococcus multilocularis | malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0073 | 0 | 0.5 |
Plasmodium vivax | lactate/malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Mycobacterium ulcerans | malate dehydrogenase | 0.0073 | 0 | 0.5 |
Trypanosoma cruzi | mitochondrial malate dehydrogenase, putative | 0.0146 | 1 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Chlamydia trachomatis | malate dehydrogenase | 0.0073 | 0 | 0.5 |
Plasmodium falciparum | lactate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0073 | 0 | 0.5 |
Leishmania major | glycosomal malate dehydrogenase | 0.0146 | 1 | 1 |
Trypanosoma brucei | glycosomal malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Plasmodium falciparum | malate dehydrogenase | 0.0073 | 0 | 0.5 |
Schistosoma mansoni | malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Leishmania major | mitochondrial malate dehydrogenase | 0.0146 | 1 | 1 |
Leishmania major | malate dehydrogenase | 0.0146 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0073 | 0 | 0.5 |
Trypanosoma brucei | mitochondrial malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Trypanosoma cruzi | glycosomal malate dehydrogenase, putative | 0.0146 | 1 | 1 |
Echinococcus granulosus | malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0073 | 0 | 0.5 |
Loa Loa (eye worm) | malate dehydrogenase | 0.0146 | 1 | 1 |
Echinococcus multilocularis | malate dehydrogenase | 0.0146 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0073 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.